However, a previous study has indicated that AQP4-IgG+ NMO is refractory to glucocorticoid treatment, and produces extensive visual field loss from the optic nerve and optic chiasma to the optic tract (2). This evidence concerns the gene AQP4 and neuromyelitis optica.